Administration Timing Is the Best Clinical Outcome Predictor for Adalimumab Administration in Crohn's Disease.
Mastronardi M, Curlo M, Cavalcanti E, Burattini O, Cuppone R, Tauro R, De Santis S, Serino G, Pesole PL, Stasi E, Caruso ML, Donghia R, Guerra V, Giorgio P, Chieppa M.
Mastronardi M, et al. Among authors: caruso ml.
Front Med (Lausanne). 2019 Nov 1;6:234. doi: 10.3389/fmed.2019.00234. eCollection 2019.
Front Med (Lausanne). 2019.
PMID: 31737635
Free PMC article.